// App-Quantinova.ai

: SGLT2 Inhibition Increases Serum Copeptin in Adults with Type 1 Diabetes (T1D)

Researchers

Presenter

  • YULIYA LYTVYN

Principal Investigators

  • PETTER BJORNSTAD

  • ALEXANDRA KATZ

  • SUNITA K. SINGH

  • LUCAS C. GODOY

  • LINH T. CHUNG

  • CARISSA L. VINOVSKIS

  • BRUCE A. PERKINS

Medical Centers

  • N/A

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

  • Infectious Diseases (ID)

Disease

  • Diabetic nephropathy

  • Type 1 diabetes mellitus

  • Renal disease

  • Hyperglycemia

  • Tuberculosis

  • Diabetes

Biomarkers

  • Copeptin

  • Hemoglobin A1c

  • Sex hormone binding globulin

Drug/Treatment

  • BI-10773

  • vasopressin Injection

  • inulin Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved